Hospira Cisplatin 100 mg/100 mL Solution for Infusion ONCO-TAIN

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

cisplatin, Quantity: 1 mg/mL

Commercializzato da:

Hospira Australia Pty Ltd

INN (Nome Internazionale):

Cisplatin

Forma farmaceutica:

Injection, intravenous infusion

Composizione:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Via di somministrazione:

Intravenous Infusion

Confezione:

1 x 100 mL

Classe:

Medicine Listed (Export Only)

Tipo di ricetta:

(S1) This Schedule is intentionally blank

Indicazioni terapeutiche:

Cisplatin is indicated for the treatment of: Metastatic non-seminomatous germ cell carcinoma Advanced and refractory carcinoma of the ovary; Advanced and refractory carcinoma of the bladder; Squamous cell carcinoma of the head and the neck.

Dettagli prodotto:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2009-03-27